Nasal symptoms can be associated with indoor mold overgrowth, even absent allergic sensitization. An alternative pathogenic mechanism—mucous membrane irritation by microbial volatile organic compounds (MVOCs)—has been proposed. We conducted a pilot human study of nasal irritation by two MVOCs, 1-octen-3-ol and 3-octanol, hypothesizing that the former would show greater irritant potency based upon the compounds’ relative irritant potencies in rodents.
Serial dilutions of the test compounds were prepared in odorless mineral oil vehicle, with headspace vapor concentrations documented by gas chromatography. Eight-step dilution series (with ascending concentration ratios ~ 1.34) were prepared. A nasal lateralization protocol was utilized. Ten subjects (seven females), aged 23–69, were each tested on four separate days, with each test compound being presented twice in alternating/counterbalanced order over the four testing days. Individual lateralization thresholds for a given compound, taken as dilution step, were averaged across subjects.
Eight subjects were reliably able to lateralize stimuli for one or both test compounds. Among the 32 testing sessions completed by these eight subjects, 1-octen-3-ol was successfully lateralized in 15/16 and 3-octanol in 11/16. The mean dilution step at threshold was 3.125 for 1-octen-3-ol and 2.58 for 3-octanol.
When presented as brief (~ 4 s.) stimuli, high concentrations of identified MVOCs can act as nasal mucosal irritants. Both detectability and repeatability, but not absolute (ppm) thresholds, exhibited compound-specific trends consistent with animal experimental data. Studies involving more protracted exposures with larger sample sizes may yield more realistic irritant threshold estimates.
At sufficiently high concentrations, MVOCs can produce nasal irritation in humans.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Abraham MH, Gola JMR, Cometto-Muñiz JE (2016) An assessment of air quality reflecting the chemo-sensory irritation impact of mixtures of volatile organic compounds. Environ Int 86:84–91
Alarie Y (1966) Irritating properties of airborne materials to the upper respiratory tract. Arch Environ Health 13(4):433–449
American Society for Testing and Materials (ASTM) (1984) Standard test method for the estimation of sensory irritancy of airborne chemicals. ASTM, Philadelphia
Araki A, Kawai T, Eitaki Y et al (2010) Relationship between selected indoor volatile organic compounds, so-called microbial VOC, and the prevalence of mucous membrane symptoms in single family homes. Sci Total Environ 408(10):2208–2215
Araki A, Kanazawa A, Kawai T et al (2012) The relationship between exposure to microbial volatile organic compound and allergy prevalence in single-family homes. Sci Total Environ 423:18–26
Baxi SN, Portnoy JM, Larenas-Linnemann D, Phipatanakul W (2016) Exposure and health effects of fungi on humans. J Allergy Clin Immunol Pract 4(3):396–404
Bush RK, Portnoy JM, Saxon A, Terr AI, Wood RA (2006) The medical effects of mold exposure. J Allergy Clin Immunol 117(2):326–333
Claeson AS, Nordin S, Sunesson AL (2009) Effects on perceived air quality and symptoms of exposure to microbially produced metabolites and compounds emitted from damp building materials. Indoor Air 19(2):102–112
Cometto-Muñiz JE, Cain WS, Abraham MH, Sánchez-Moreno R, Gil-Lostes J (2010) Nasal chemosensory irritation in humans. In: Morris JB, Shusterman DJ (eds) Toxicology of the Nose and Upper Airways. Informa Healthcare USA, New York, pp 187–202
Elke K, Begerow J, Oppermann H, Kramer U, Jermann E, Dunemann L (1999) Determination of selected microbial volatile organic compounds by diffusive sampling and dual-column capillary GC-FID—a new feasible approach for the detection of an exposure to indoor mould fungi? J Environ Monit 1(5):445–452
Ernstgard L, Norback D, Nordquist T, Wieslander G, Walinder R, Johanson G (2013) Acute effects of exposure to vapors of 3-methyl-1-butanol in humans. Indoor Air 23(3):227–235
Green BG, Dalton P, Cowart B, Shaffer G, Rankin K, Higgins J (1996) Evaluating the “labeled magnitude scale” for measuring sensations of taste and smell. Chem Senses 21(3):323–334
Jaakkola MS, Quansah R, Hugg TT, Heikkinen SA, Jaakkola JJ (2013) Association of indoor dampness and molds with rhinitis risk: a systematic review and meta-analysis. J Allergy Clin Immunol 132(5):1099–110.e18
Kawaguchi M, Mendell M, Chrysochou G, Shusterman D, Hutchinson J, Kumagai K. (2014) Indoor dampness and mold as indicators of respiratory health risks, part 7: a review of microbial volatile organic compounds (MVOCs) observed under damp conditions. Indoor Air 2014: The 13th International Conference on Indoor Air Quality and Climate. Hong Kong: July 7-12, 2014
Kim JL, Elfman L, Mi Y, Wieslander G, Smedje G, Norbäck D (2007) Indoor molds, bacteria, microbial volatile organic compounds and plasticizers in schools—associations with asthma and respiratory symptoms in pupils. Indoor Air 17:153–163
Korpi A, Kasanen JP, Alarie Y, Kosma VM, Pasanen AL (1999) Sensory irritating potency of some microbial volatile organic compounds (MVOCs) and a mixture of five MVOCs. Arch Environ Health 54(5):347–352
Kuwabara Y, Alexeeff GV, Broadwin R, Salmon AG (2007) Evaluation and application of the RD50 for determining acceptable exposure levels of airborne sensory irritants for the general public. Environ Health Perspect 115(11):1609–1616
Lundstrom JN, Gordon AR, Wise P, Frasnelli J (2012) Individual differences in the chemical senses: is there a common sensitivity? Chem Senses 37(4):371–378
Mendell MJ, Mirer AG, Cheung K, Tong M, Douwes J (2011) Respiratory and allergic health effects of dampness, mold, and dampness-related agents: a review of the epidemiologic evidence. Environ Health Perspect 119(6):748–756
SaECaNet. Calculation of Antoine equation. Uploaded September 29, 2010. Accessed at: http://www.saecanet.com/20100716/saecanet_calculation_page.php?pagenumber=536
Schleibinger H, Laussmann D, Brattig C, Mangler M, Eis D, Ruden H (2005) Emission patterns and emission rates of MVOC and the possibility for predicting hidden mold damage? Indoor Air 15(Suppl 9):98–104
Schleibinger H, Laussmann D, Bornehag CG, Eis D, Rueden H (2008) Microbial volatile organic compounds in the air of moldy and mold-free indoor environments. Indoor Air 18:113–124
Shusterman D, Murphy MA, Balmes J (2003) Differences in nasal irritant sensitivity by age, gender, and allergic rhinitis status. Int Arch Occup Environ Health 76(8):577–583
Shusterman D, Matovinovic E, Salmon A (2006) Does Haber’s law apply to human sensory irritation? Inhal Toxicol 18(7):457–471
Walinder R, Ernstgard L, Johanson G, Norback D, Venge P, Wieslander G (2005) Acute effects of a fungal volatile compound. Environ Health Perspect 113:1775–1778
Walinder R, Ernstgard L, Norback D, Wieslander G, Johanson G (2008) Acute effects of 1-octen-3-ol, a microbial volatile organic compound (MVOC)—an experimental study. Toxicol Lett 181(3):141–147
Yaws CL, Narashimhan P, Prasad K, Gabbula C. (2005) Yaws’ Handbook of Antoine Coefficients for Vapor Pressure (2nd Electronic Edition). September 12, 2005. Knovel. Online version available at: http://app.knovel.com/hotlink/toc/id:kpYHACVPEH/yaws-handbook-antoine/yaws-handbook-antoine
We wish to acknowledge the assistance of Drs. Wenhao Chen, Janet Macher, and Mark Mendell (of the Indoor Air Quality Section of the California Department of Public Health), who provided advice on study design—as well as hands-on technical assistance—at various stages of the project. We also wish to acknowledge the assistance of Dr. Enrique Cometto-Muniz of the University of California, San Diego in the selection of appropriate study materials, and Drs. Scott Meschke and Russell Dills of the University of Washington for providing input on an earlier version of this proposal.
Funds for this study were provided by the Department of Medicine, Division of Occupational and Environmental Medicine, University of California, San Francisco. In-kind support for analytical procedures was provided by the California Department of Public Health, Indoor Air Quality Section.
Conflict of Interest
The authors declare that they have no conflict of interest.
- Inter-test interval
The minimum time allowed between successive threshold tests (at least 1 day)
- Inter-trial interval
The time allowed between successive trials (nominally, 60 s)
- Lateralization threshold
For a given test compound, the average (ascending concentration) step at which an individual successfully lateralizes stimuli on five successive trials
Stimulus dilution step (0 = most concentrated; 7 = most dilute)
- Stimulus order:
i.e., “1212” vs. “2121”
Half of subjects with each of two alternating stimulus orders
- Threshold test
The entire testing procedure for a given day, incorporating five trials at each (ascending concentration) step until five of five are correctly lateralized
The simultaneous presentation of a stimulus and blank stimulus to opposite nostrils, with randomized lateralization
Visual analog scale [rating of subjective nasal irritation]
About this article
Cite this article
Shusterman, D., Wang, P. & Kumagai, K. Nasal Trigeminal Perception of Two Representative Microbial Volatile Organic Compounds (MVOCs): 1-Octen-3-ol and 3-Octanol—a Pilot Study. Chem. Percept. 11, 27–34 (2018). https://doi.org/10.1007/s12078-017-9235-5
- Microbial volatile organic compounds (MVOCs)
- Nasal irritation
- Sensory irritation
- Trigeminal irritation